SCHEMBL21466071

SCHEMBL21466071

CCOC(=O)C(Cc1ccc(O)cc1)NC(=O)CCc1ccc(O)cc1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ BACE1 P56817 1/20 0.50
▸ MDM4 O15151 1/20 0.50
▸ MDM2 Q00987 1/20 0.50
▸ GRIA1 P42261 1/20 0.47
▸ CHRND Q07001 6/20 0.47
▸ CHRNA1 P02708 2/20 0.47
▸ CHRNG P07510 2/20 0.47
▸ CHRNB1 P11230 2/20 0.47
▸ LNPEP Q9UIQ6 1/20 0.47
▸ HDAC1 Q13547 2/20 0.46
▸ HDAC6 Q9UBN7 2/20 0.46
▸ POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29352083 1.00 ALDH1A1 (0.50) ALDH1A1NPSR1BACE1MDM4MDM2
Bicarbonate SCHEMBL30452528 0.97 MDM4 (0.51) ALDH1A1NPSR1BACE1MDM4MDM2
SCHEMBL3929918 0.95 ALDH1A1 (0.57) ALDH1A1BACE1MDM4MDM2GRIA1
SCHEMBL12009639 0.95 ALDH1A1 (0.57) ALDH1A1BACE1MDM4MDM2GRIA1
SCHEMBL29349987 0.91 ALDH1A1 (0.46) ALDH1A1NPSR1BACE1MDM4MDM2
SCHEMBL14049475 0.91 ALDH1A1 (0.44) ALDH1A1NPSR1BACE1MDM4MDM2
SCHEMBL23864850 0.90 ALDH1A1 (0.47) ALDH1A1NPSR1BACE1MDM4MDM2
SCHEMBL13123764 0.90 ALDH1A1 (0.48) ALDH1A1NPSR1BACE1MDM4MDM2
SCHEMBL21884113 0.90 ALDH1A1 (0.46) ALDH1A1NPSR1BACE1MDM4MDM2
SCHEMBL31072235 0.90 ALDH1A1 (0.48) ALDH1A1NPSR1BACE1MDM4MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3635029-B1 SYNTHESIS OF TYROSINE DERIVED POLYARYLATES MEDTRONIC INC (US) 2021-03-17 — — EP claimed
EP-3312155-B1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES UNIV RUTGERS (US) 2020-08-05 — — EP claimed
US-11359050-B2 Synthesis of tyrosine derived polyarylates MEDTRONIC, INC. (US) 2022-06-14 — — US disclosed
US-20200354514-A1 SYNTHESIS OF TYROSINE DERIVED POLYARYLATES MEDTRONIC, INC. (US) 2020-11-12 — — US disclosed
US-10793670-B2 Synthesis of tyrosine derived polyarylates MEDTRONIC, INC. (US) 2020-10-06 — — US disclosed
US-20200171214-A1 BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION DREI LILIEN PVG GMBH & CO. KG (DE) 2020-06-04 — — US disclosed
US-10442757-B2 Synthesis of tyrosine derived diphenol monomers MEDTRONIC, INC. (US) 2019-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10442757-B2 Synthesis of tyrosine derived diphenol monomers TYR, TH, TYRO3 ALDH1A1 1997/4885NPSR1 3757/4885BACE1 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback